Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Phillip Alper is active.

Publication


Featured researches published by Phillip Alper.


Archive | 2008

Compounds and compositions as modulators of GPR119 activity

Phillip Alper; Mihai Azimioara; Christopher Cow; Robert Epple; Songchun Jiang; Gerald Lelais; Pierre-Yves Michellys; Daniel Mutnick; Victor Nikulin


Archive | 2006

Compounds and compositions as tpo mimetics

Thomas H. Marsilje; Wenshuo Lu; Phillip Alper; Daniel Mutnick; Yun He


Bioorganic & Medicinal Chemistry Letters | 2006

Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.

Phillip Alper; Hong Liu; Arnab K. Chatterjee; KhanhLinh T. Nguyen; David C. Tully; Christine Tumanut; Jun Li; Jennifer L. Harris; Tove Tuntland; Jonathan Chang; Perry Gordon; Thomas Hollenbeck; Donald S. Karanewsky


Archive | 2011

COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS

David C. Tully; Agnes Vidal; Daniel Mutnick; Phillip Alper


Archive | 2006

HETEROTETRACYCLIC COMPOUNDS AS TPO MIMETICS

Phillip Alper; Thomas H. Marsilje; Arnab K. Chatterjee; Wenshuo Lu; Daniel Mutnick; Michael J. Roberts; Yun He


Archive | 2017

composto composições como moduladores da atividade de gpr119

Christopher Cow; Daniel Mutnick; Gerald Lelais; Lucas Westcott-Baker; Mihai Azimioara; Phillip Alper; Pierre-Yves Michellys; Robert Epple; Songchun Jiang; Victor Nikulin


Archive | 2017

compostos e composições como moduladores da atividades de gpr119

Daniel Mutnick; H. Michael Petrassi; Phillip Alper; Pierre-Yves Michellys; Robert Epple; Victor Nikulin


Archive | 2013

Compuestos derivados de azabiciclo[3.2.1]octano; agonista del receptor x fernesoide (fxr); proceso para preparar los compuestos; compuesto intermediario; composicion farmaceutica y combinacion farmaceutica que comporenden un compuesto; y uso de los compuestos en la preparacion de medicamentos para el tratamiento de dislipidemia.

David C. Tully; Paul Vincent Rucker; Phillip Alper; Daniel Mutnick; Donatella Chianelli


Archive | 2011

Compositions et procédés de modulation des récepteurs farnésoïdes x

David C. Tully; Agnes Vidal; Daniel Mutnick; Phillip Alper


Archive | 2010

Composés et compositions pouvant servir de modulateurs de l'activité du gpr119

Phillip Alper; Mihai Azimioara; Christopher Cow; Robert Epple; Gerald Lelais; Daniel Mutnick; Victor Nikulin

Collaboration


Dive into the Phillip Alper's collaboration.

Top Co-Authors

Avatar

Daniel Mutnick

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Robert Epple

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

David C. Tully

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Victor Nikulin

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Christopher Cow

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Mihai Azimioara

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Pierre-Yves Michellys

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Arnab K. Chatterjee

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Songchun Jiang

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Yun He

Chongqing University

View shared research outputs
Researchain Logo
Decentralizing Knowledge